{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:46:59Z","timestamp":1793227619241,"version":"4.5.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gastroesophageal reflux disease (GERD) is a common chronic upper gastrointestinal disorder that causes discomfort and increases the risk of esophageal adenocarcinoma. The global burden of GERD has steadily increased, establishing it as a critical public health issue. This study systematically evaluated the global, regional, and national burden of GERD from 1990 to 2021, revealing epidemiological trends and regional disparities to inform targeted intervention strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We utilized data from the 2021 Global Burden of Disease Study (GBD) to assess the prevalence, incidence, and years lived with disability (YLDs) of GERD. Key indicators included age-standardized prevalence rate (ASPR), age-standardized incidence rate (ASIR), age-standardized YLDs rate (ASYR), and estimated annual percentage change (EAPC). Analyses were stratified by age, gender, and socio-demographic index (SDI). Age-period-cohort (APC) models were applied to examine trends in the 15\u201349 age group, and Bayesian APC models were used to project future trends.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In 2021, global GERD prevalence reached 825.6 million (95% uncertainty interval: 732.99\u2013925.56 million). From 1990 to 2021, incident cases, prevalent cases, and YLDs rose by 83.16, 80.06, and 82.46%, respectively. The ASIR, ASPR, and ASYR all showed upward trends, with EAPCs of 0.097, 0.076, and 0.083. The highest burden of ASIR, ASPR, and ASYR was observed in Tropical Latin America in 2021, while the lowest was in East Asia. Regions with lower SDI had higher ASIR, ASPR, and ASYR. In the 15\u201349 age group, the GERD burden increased with age across all SDI regions, with unfavorable period effects observed in high and high-middle SDI regions, as well as adverse cohort effects in high-middle and middle SDI regions. Projections indicate that by 2035, global GERD cases in this age group will reach 527.2 million (ASPR: 12,082.06\/100,000), with 214.6 million incident cases (ASIR: 4,916.68\/100,000) and 4.1 million YLDs (ASYR: 94.47\/100,000).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>GERD poses a growing global health challenge. Insights from these observed epidemiological patterns can assist policymakers in developing targeted measures to reduce its impact, particularly in high-risk regions and younger demographics.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2025.1576527","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T05:43:44Z","timestamp":1752126224000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Global, regional, and national burden of gastroesophageal reflux disease (1990\u20132021): age-period-cohort analysis and Bayesian projections"],"prefix":"10.3389","volume":"13","author":[{"given":"Liumei","family":"Mo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxian","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jincheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhuo","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1001\/jama.2020.21573","article-title":"Gastroesophageal reflux disease","volume":"324","author":"Maret-Ouda","year":"2020","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1053\/j.gastro.2019.12.014","article-title":"Prevalence of gastroesophageal reflux disease and proton pump inhibitor-refractory symptoms","volume":"158","author":"Delshad","year":"2020","journal-title":"Gastroenterology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/MCG.0000000000000854","article-title":"World gastroenterology organisation global guidelines: GERD global perspective on gastroesophageal reflux disease","volume":"51","author":"Hunt","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S2468-1253(19)30408-X","article-title":"The global, regional, and national burden of gastro-oesophageal reflux disease in 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1080\/07853890.2022.2074535","article-title":"Global, regional and national burden of gastroesophageal reflux disease, 1990-2019: update from the GBD 2019 study","volume":"54","author":"Zhang","year":"2022","journal-title":"Ann Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1053\/j.gastro.2017.07.045","article-title":"Presentation and epidemiology of gastroesophageal reflux disease","volume":"154","author":"Richter","year":"2018","journal-title":"Gastroenterology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1136\/gutjnl-2016-313589","article-title":"Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis","volume":"67","author":"Eusebi","year":"2018","journal-title":"Gut"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1186\/s12889-023-15272-z","article-title":"Burden of gastroesophageal reflux disease in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019","volume":"23","author":"Li","year":"2023","journal-title":"BMC Public Health"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.7150\/ijbs.65066","article-title":"Current advancement on the dynamic mechanism of gastroesophageal reflux disease","volume":"17","author":"Zheng","year":"2021","journal-title":"Int J Biol Sci"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41572-021-00287-w","article-title":"Gastro-oesophageal reflux disease","volume":"7","author":"Fass","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.5056\/jnm18140","article-title":"The changing epidemiology of gastroesophageal reflux disease: are patients getting younger?","volume":"24","author":"Yamasaki","year":"2018","journal-title":"J Neurogastroenterol Motil"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1478-7954-1-4","article-title":"A generic model for the assessment of disease epidemiology: the computational basis of DisMod II","volume":"1","author":"Barendregt","year":"2003","journal-title":"Popul Health Metrics"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1002\/sim.2764","article-title":"Age-period-cohort models for the Lexis diagram","volume":"26","author":"Carstensen","year":"2007","journal-title":"Stat Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"106250","DOI":"10.1016\/j.jinf.2024.106250","article-title":"Global temporal trends and projections of acute hepatitis E incidence among women of childbearing age: age-period-cohort analysis 2021","volume":"89","author":"Huang","year":"2024","journal-title":"J Infect"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021","volume":"402","year":"2023","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s10654-022-00842-z","article-title":"Adiposity, diabetes, lifestyle factors and risk of gastroesophageal reflux disease: a Mendelian randomization study","volume":"37","author":"Yuan","year":"2022","journal-title":"Eur J Epidemiol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"5814","DOI":"10.1038\/s41598-020-62795-1","article-title":"Global prevalence and risk factors of gastro-oesophageal reflux disease (GORD): systematic review with meta-analysis","volume":"10","author":"Nirwan","year":"2020","journal-title":"Sci Rep"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1053\/j.gastro.2018.05.036","article-title":"Older age reduces upper esophageal sphincter and esophageal body responses to simulated slow and ultraslow reflux events and post-reflux residue","volume":"155","author":"Mei","year":"2018","journal-title":"Gastroenterology"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"700","DOI":"10.3949\/ccjm.89a.22059","article-title":"Evaluation and management of gastroesophageal reflux disease: a brief look at the updated guidelines","volume":"89","author":"Sasankan","year":"2022","journal-title":"Cleve Clin J Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.3748\/wjg.15.1690","article-title":"Body weight, lifestyle, dietary habits and gastroesophageal reflux disease","volume":"15","author":"Festi","year":"2009","journal-title":"World J Gastroenterol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/JS9.0000000000001902","article-title":"The global, regional, and national patterns of change in the burden of non-malignant upper gastrointestinal diseases from 1990 to 2019 and the forecast for the next decade","volume":"111","author":"Bai","year":"2024","journal-title":"Int J Surg"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"980603","DOI":"10.3389\/fpubh.2022.980603","article-title":"Shift work is significantly and positively associated with possible gastro-esophageal reflux disease: a meta-analysis study","volume":"10","author":"Chen","year":"2022","journal-title":"Front Public Health"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3390\/nu16030464","article-title":"The efficacy of dietary interventions in patients with gastroesophageal reflux disease: a systematic review and Meta-analysis of intervention studies","volume":"16","author":"Lakananurak","year":"2024","journal-title":"Nutrients"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2147\/TCRM.S296680","article-title":"Dietary and lifestyle factors related to gastroesophageal reflux disease: a systematic review","volume":"17","author":"Zhang","year":"2021","journal-title":"Ther Clin Risk Manag"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e82997","DOI":"10.7759\/cureus.82997","article-title":"Prevalence and lifestyle factors associated with gastroesophageal reflux disease symptoms among adults in Saudi Arabia: a cross-sectional study","volume":"17","author":"Alatawi","year":"2025","journal-title":"Cureus"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2147\/IJGM.S223882","article-title":"Identifying key challenges facing healthcare systems in Africa and potential solutions","volume":"12","author":"Oleribe","year":"2019","journal-title":"Int J Gen Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12875-024-02336-1","article-title":"Barriers and strategies for primary health care workforce development: synthesis of evidence","volume":"25","author":"Endalamaw","year":"2024","journal-title":"BMC Prim Care"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"575","DOI":"10.5056\/jnm16138","article-title":"Sex and gender differences in gastroesophageal reflux disease","volume":"22","author":"Kim","year":"2016","journal-title":"J Neurogastroenterol Motil"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1056\/NEJM199903183401101","article-title":"Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma","volume":"340","author":"Lagergren","year":"1999","journal-title":"N Engl J Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1053\/j.gastro.2019.05.056","article-title":"Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin","volume":"157","author":"Moayyedi","year":"2019","journal-title":"Gastroenterology"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1136\/gutjnl-2013-306393","article-title":"Symptomatic reflux disease: the present, the past and the future","volume":"63","author":"Boeckxstaens","year":"2014","journal-title":"Gut"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1576527\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T13:39:23Z","timestamp":1752154763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1576527\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":32,"alternative-id":["10.3389\/fpubh.2025.1576527"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1576527","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"article-number":"1576527"}}